Cargando…
Improving pediatric multiple sclerosis interventional phase III study design: a meta-analysis
BACKGROUND: To support innovative trial designs in a regulatory setting for pediatric-onset multiple sclerosis (MS), the study aimed to perform a systematic literature review and meta-analysis of relapse rates with interferon β (IFN β), fingolimod, and natalizumab and thereby demonstrate potential b...
Autores principales: | Graves, Jennifer S., Thomas, Marius, Li, Jun, Shah, Anuja R., Goodyear, Alexandra, Lange, Markus R., Schmidli, Heinz, Häring, Dieter A., Friede, Tim, Gärtner, Jutta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066624/ https://www.ncbi.nlm.nih.gov/pubmed/35514529 http://dx.doi.org/10.1177/17562864211070449 |
Ejemplares similares
-
Blinded continuous monitoring in clinical trials with recurrent event endpoints
por: Friede, Tim, et al.
Publicado: (2018) -
Post-natalizumab disease reactivation in multiple sclerosis:
systematic review and meta-analysis
por: Prosperini, Luca, et al.
Publicado: (2019) -
Effects of non-invasive brain stimulation in multiple sclerosis: systematic review and meta-analysis
por: Kan, Rebecca L.D., et al.
Publicado: (2022) -
Maternal Body Mass Index, Diabetes, and Gestational Weight Gain and Risk for Pediatric Cancer in Offspring: A Systematic Review and Meta-Analysis
por: Marley, Andrew R, et al.
Publicado: (2022) -
Disease‐modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta‐analysis
por: Valizadeh, Amir, et al.
Publicado: (2022)